Press Release
Select category
  • Select category
  • Aerospace & Defense
    • Aircraft Components
    • Aircraft Material
    • Aviation
    • Defense
    • Marine
    • Security
    • Space
    • Technology
  • Agriculture
    • Materials
    • Technology
  • Automotive
    • Automotive Systems
    • Chemical Automotive
    • Component
    • Freight & Logistics
    • Material
    • Technology
    • Transport Mode
    • Utility
    • Vehicle
  • Automotive (CI)
  • BFSI
    • Banking
  • Chemical and Materials
    • Advanced Materials
    • Chemical
    • Coatings and Additives
    • Composites
    • Paints
    • Textile
  • Chemical and Materials (CI)
  • Construction & Manufacturing
    • Agriculture
    • Construction and Improvements
    • Construction Materials
    • Decor
    • Equipment and Machinery
    • Industrial Equipment & Automation
    • Packaging
  • Consumer & Goods
    • Baby products and supplies
    • Beauty & Personal Care
    • Consumer
    • Home Products
    • Retail
    • Sports & Fitness
    • Travel
  • Electronics and Semiconductor
    • Communication Equipment
    • Display Technology
    • Electronic Component
    • Electronic Devices
    • Emerging Technologies
    • Security
    • Semiconductor
    • Sensor & Control
    • Technology
  • Energy and Power
    • Conventional Energy
    • Equipment
    • Power
    • Renewable Energy
    • Services
    • Storage and Distribution
    • Technology
    • Utility
  • Food & Beverage
    • Baby Food
    • Dairy Products
    • Food Ingredient
    • Food Products
    • Food Services and Hospitality
    • Packaging
    • Processed Food
  • Healthcare
  • Healthcare (CI)
  • Industrial Automation & Equipment
    • Component
  • Information and Communication Technology
    • Communication
    • Data Center
    • Data Center and Networking
    • Emerging Technologies
    • Entertainment Technologies
    • Security
    • Software and Services
    • Technology
  • Information and Communication Technology ICT (CI)
  • Life Science
    • Biotechnology
    • Diagnostics and Biotech
    • Healthcare Equipment
    • Healthcare IT
    • Medical Devices
    • Packaging
    • Pharmaceutical
    • Therapeutic
  • Miscellaneous
    • BFSI
    • Education and Training
  • Uncategorized
Evolve Business Intelligence Evolve Business Intelligence
  • Home
  • About Us
  • Services
  • Market Reports
    • Automotive
      • Component
      • Vehicle
      • Chemical Automotive
      • Technology
      • Freight & Logistics
      • Material
      • Technology
      • Transport Mode
      • Utility
      • Vehicle
    • Chemical and Materials
      • Chemical
      • Advanced Materials
      • Coatings and Additives
      • Composites
      • Paints
      • Textile
    • Aerospace & Defense
      • Marine
      • Security
      • Technology
      • Aircraft Components
      • Aircraft Material
    • Construction & Manufacturing
    • Electronics and Semiconductor
      • Display Technology
      • Electronic Component
      • Electronic Devices
      • Semiconductor
      • Communication Equipment
      • Emerging Technologies
      • Security
      • Sensor & Control
      • Technology
    • Energy and Power
    • Life Science
    • Consumer & Goods
      • Baby products and supplies
      • Beauty & Personal Care
      • Consumer
      • Home Products
    • Information and Communication Technology
      • Emerging Technologies
      • Entertainment Technologies
      • Security
      • Communication
      • Data Center
      • Data Center and Networking
      • Software and Services
      • Technology
  • Competitive Intelligence (CI)
    • Automotive (CI)
    • Chemical and Materials (CI)
    • Construction & Manufacturing (CI)
    • Energy and Power (CI)
    • Electronics and Semiconductor (CI)
    • Healthcare (CI)
    • Information and Communication Technology ICT (CI)
  • Become a reseller
  • Contact Us
Menu
Evolve Business Intelligence Evolve Business Intelligence
Press Release
Life Science
Click to enlarge
Home » Our Report Repository » Global Endometriosis Treatment Market Market Analysis and Global Forecast (2022-2030) with COVID Impact Analysis
Information and Communication
Global Supply Side Platform (SSP) Market Analysis and Global Forecast (2023-2033) with COVID Impact Analysis $ 3,475.00
Back to products
Information and Communication
Global Metaverse NFT Market Analysis and Global Forecast (2022-2030) with COVID Impact Analysis $ 3,475.00

Global Endometriosis Treatment Market Market Analysis and Global Forecast (2022-2030) with COVID Impact Analysis

$ 3,475.00

Global Endometriosis Treatment Market Research Report: Information By Drug Type (Progestin, Gonadotropins Releasing Hormone Agonists, Oral Contraceptive Pills, Non-Steroidal Anti-Inflammatory Drugs, and Others) By Treatment Type (Pain Management and Hormonal Therapies), By Distribution Channel (Hospital Pharmacies, E-Pharmacies, Retail Pharmacies, and Others) and Region — Forecast till 2030

Report Code: EB_ICT | Page: 160 | Published Date: Upcoming

Category: Healthcare Tags: Endometriosis Treatment Analysis, Endometriosis Treatment Companies, Endometriosis Treatment Forecast, Endometriosis Treatment Growth, Endometriosis Treatment Industry, Endometriosis Treatment Restraints, Endometriosis Treatment Share, Endometriosis Treatment Size, Endometriosis Treatment Trends
Share:
  • Description
  • Table of Contents
  • Connect to Analyst
  • Research Methodology
Description

Market Overview

The global Endometriosis Treatment market size is projected to reach approximately $ 2.332 billion by 2030, at a CAGR of 3.4% from 2022 to 2030. Endometriosis is a condition in which tissue that lines the inner part of the uterus grows outside the uterus. It causes pain, scarring, and bowel problems. Endometriosis is a condition that may cause internal bleeding as well as pain. This condition is characterized by having endometrial tissue growing in places where it’s not supposed to grow, like the fallopian tubes, ovaries, and pelvis. Endometriosis causes many symptoms, including pain in the pelvic region, which is typical for women during different periods of the month. It may also result in pain during intercourse and excessive bleeding.

COVID-19 Impact Analysis

The Endometriosis Treatment market was severely impacted by the spread of the Coronavirus pandemic. The market was affected due to the spread of the disease to other countries. In addition, the spread of the coronavirus has led to the lack of quality treatment in the market. This is because most countries have banned the entry of products that are used in the treatment of endometriosis. In addition, there is also no government support to promote products that are used in the treatment of the disease.

Market Dynamics

The Endometriosis Treatment market is projected to grow on account of the availability and research into new drugs. This will be supported by an increase in Endometriosis prevalence, a robust pipeline for potential advanced treatment models and trends, and increased awareness about Endometriosis.

Drivers:

⮚     Increased Research on the Development of New Drugs

Increased Research activities and increased funding from the governments of various countries to develop new drugs for the global endometriosis treatment market are expected to be a major drivers of the market growth forecasted period. In 2017, drug manufacturer AbbVie submitted an application to the US FDA for a new drug called Elagolix. They are working in cooperation with a company called Neurocrine Biosciences Inc. Elagolix is an orally administered gonadotropin-releasing hormone (GnRH) antagonist which is being evaluated for the management of pain during endometriosis.

Restraint:

  • Lack of non-invasive diagnostic tests in the market

Women with endometriosis typically wait a long time before receiving the necessary diagnosis. Women do not seek help timely, during which their disease can progress significantly, potentially impacting their fertility. There is a long-known delay in the diagnosis of endometriosis because the condition can be definitively diagnosed only via laparoscopy, which is an invasive surgical procedure. However, better diagnostic techniques are becoming more prevalent, such as biomarkers. These can help hasten the diagnosis process and avoid invasive surgery if unnecessary.

Opportunity:

⮚     Growing Prevalence and Awareness of Endometriosis

The rising prevalence of endometriosis is leading to an increase in awareness among women regarding treatment options and research developments. With a significant increase in the occurrence of this disease, it is clear that more people are willing to invest in research and development. This allows the market to grow and provides additional opportunities.

 

Segment Overview

By Drug Type

Based on the Drug Type, the Endometriosis Treatment market is segmented based on Progestin, Gonadotropins Releasing Hormone Agonists, Oral Contraceptive Pills, Non-Steroidal Anti-Inflammatory Drugs, and Others. The Oral Contraceptive Segment is anticipated to account for the large market share. Oral contraceptives are the first-line treatment for patients who do not have contraindications. They are highly effective in preventing recurrent pelvic pain and associated endometriosis lesions. However, they are associated with possible side effects such as changes in mood, nausea, and an elevated blood pressure level.

By Treatment Type

Based on Treatment Type, the global Endometriosis Treatment market has been divided into Pain Management and Hormonal Therapies. The Hormonal Therapies segment is expected to hold the largest market share. This form of treatment is the most common one due to its effectiveness in decreasing estrogen production and preventing periods from coming.

By Distribution Channel

Based on Distribution Channel, the global Endometriosis Treatment market has been divided into Hospital Pharmacies, E-Pharmacies, Retail Pharmacies, and Others. The Hospital Pharmacies and Retail Pharmacies segments are expected to hold the largest market share. The high patient pool in hospitals and visiting retailers and the high cost of the medical treatment contribute to this result

Global Endometriosis Treatment Market Share, by Segmentation

Regional Analysis

Based on region, the global Endometriosis Treatment market has been divided into North America, Europe, Asia-Pacific, and the Rest of the World. North America is projected to dominate the use of the Endometriosis Treatment market followed by the Asia-Pacific and Europe regions.

North America Market

North America is expected to account for the highest Endometriosis Treatment revenue in the upcoming years. The prevalence of chronic gynecological disorders like Endometriosis has been rising in the United States and around the world. Women are now more open to talking about their reproductive health, including their menstrual cycle and menopause, which is leading to increased awareness of female reproductive health. Advances in technology have also paved the way for new services and treatments.

Asia-Pacific Market

The Asia-Pacific region is expected to become the fastest-growing Endometriosis Treatment market over the forecast period due to the government initiatives to improve women’s health and safety. In 2018, the government of Australia allocated about $2.5 million for research in the field of Endometriosis.

Competitive Landscape

The market comprises tier-1, tier-2, and local players. With their wide product portfolios, tier-1 and tier-2 players have a global reach. Because of their strategic innovations and broad regional presence, companies such as Astra Zeneca Plc., Eli Lilly and Company, Astellas Pharma, Bayer AG, Meditrina Pharmaceuticals, Abbvie, PfizerInc, Takeda Pharmaceutica, and Neurocrine Biosciences Inc, lead the global Endometriosis Treatment business. To increase their market position and attract a wide consumer base, the businesses are employing various strategies, such as growth, product releases, and alliances.

Prominent Players:

  • Eli Lilly and Company
  • AstraZeneca Plc.
  • Bayer AG
  • Astellas Pharma
  • Abbvie
  • Meditrina Pharmaceuticals
  • Pfizer Inc.
  • Neurocrine Biosciences Inc.
  • Takeda Pharmaceutical Company

In 2018, Bayer collaborated with Evotec and announced phase I trials for a new drug that is a treatment for endometriosis

Scope of the Report

Global Endometriosis Treatment Market, by Drug Type

  • Progestin
  • Gonadotropins Releasing Hormone Agonists
  • Oral Contraceptive Pills
  • Non-Steroidal Anti-Inflammatory Drugs
  • Others

Global Endometriosis Treatment Market, by Treatment Type

  • Pain Management
  • Hormonal Therapies

Global Endometriosis Treatment Market, by Distribution Channel

  • Hospital Pharmacies
  • E-Pharmacies
  • Retail Pharmacies
  • Others

Global Endometriosis Treatment Market, by Region

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Rest of Asia Pacific
  • Rest of the World

 

Parameters Indicators
Market Size 2030: $ 2.332  Billion
CAGR 3.4% CAGR (2022-2030)
Base year 2021
Forecast Period 2022-2030
Historical Data 2020
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Key Segmentations Drug Type, Treatment Type, Distribution Channel
Geographies Covered North America, Europe, Asia-Pacific, Latin America, Middle East, Africa
Key Vendors Astra Zeneca Plc., Eli Lilly and Company, Astellas Pharma, Bayer AG, Meditrina Pharmaceuticals, Abbvie, PfizerInc, Takeda Pharmaceutica, and Neurocrine Biosciences Inc
Key Market Opportunities Growing Prevalence and Awareness of Endometriosis
Key Market Drivers Increased Research on Development of New Drugs

 

REPORT CONTENT BRIEF:

  • High-level analysis of the current and future Endometriosis Treatment market trends and opportunities
  • Detailed analysis of current market drivers, restraining factors, and opportunities in the future
  • Endometriosis Treatment market historical market size for the year 2020, and forecast from 2021 to 2028
  • Endometriosis Treatment market share analysis at each product level
  • Competitor analysis with a detailed insight into its product segment, financial strength, and strategies adopted.
  • Identifies key strategies adopted including product launches and developments, mergers and acquisitions, joint ventures, collaborations, and partnerships as well as funding taken and investment done, among others.
  • To identify and understand the various factors involved in the global Endometriosis Treatment market affected by the pandemic
  • To provide a detailed insight into the major companies operating in the market. The profiling will include the financial health of the company past 2-3 years with segmental and regional revenue breakup, product offering, recent developments, SWOT analysis, and key strategies.

For more details mail us at

[email protected]

Ask a question / additional requirement













    Press Release

    • The Telemedicine Market Is Estimated To Record a CAGR of Around 29.2% During The Forecast Period

      The Telemedicine Market Is Estimated To Record a CAGR of Around 29.2% During The Forecast Period

      May 26, 2023

    • The Population Health Management Market Is Estimated To Record a CAGR of Around 13.1% During The Forecast Period

      The Population Health Management Market Is Estimated To Record a CAGR of Around 13.1% During The Forecast Period

      May 24, 2023

    • Medical Tourism Market Is Estimated To Record a CAGR of Around 22.9% During The Forecast Period

      Medical Tourism Market Is Estimated To Record a CAGR of Around 22.9% During The Forecast Period

      May 24, 2023

    • The Mobile Health Market Is Estimated To Record a CAGR of Around 10.82% During The Forecast Period

      The Mobile Health Market Is Estimated To Record a CAGR of Around 10.82% During The Forecast Period

      May 24, 2023

    • The Negative Pressure Wound Therapy Market Is Estimated To Record a CAGR of Around 6.4% During The Forecast Period

      The Negative Pressure Wound Therapy Market Is Estimated To Record a CAGR of Around 6.4% During The Forecast Period

      May 24, 2023

    • Hard-Surface Flooring Market Is Estimated To Record a CAGR of Around 5.12% During The Forecast Period

      Hard-Surface Flooring Market Is Estimated To Record a CAGR of Around 5.12% During The Forecast Period

      May 8, 2023

    • The Composite Doors & Windows Market Is Estimated To Record a CAGR of Around 7.7% During The Forecast Period

      The Composite Doors & Windows Market Is Estimated To Record a CAGR of Around 7.7% During The Forecast Period

      May 8, 2023

    • The Medical Supplies Market Is Estimated To Record a CAGR of Around 3.76% During The Forecast Period

      The Medical Supplies Market Is Estimated To Record a CAGR of Around 3.76% During The Forecast Period

      April 25, 2023

    • The Cosmetic Surgery Market Is Estimated To Record a CAGR of Around 12.20% During The Forecast Period

      The Cosmetic Surgery Market Is Estimated To Record a CAGR of Around 12.20% During The Forecast Period

      April 24, 2023

    • Global Wearable Medical Devices Market Is Estimated To Record a CAGR of Around 14.06% During The Forecast Period

      Global Wearable Medical Devices Market Is Estimated To Record a CAGR of Around 14.06% During The Forecast Period

      April 23, 2023

    Endometriosis Treatment Market Market FAQs

    1. What is the study period of this market?
    • The study period of the global Endometriosis Treatment market is 2020 – 2030
    1. What is the growth rate of the global Endometriosis Treatment market?
    • The global Endometriosis Treatment market is growing at a CAGR of ~ 4% over the next 7 years
    1. Which region has the highest growth rate in the global Endometriosis Treatment market?
    • Asia Pacific is expected to register the highest CAGR during 2022-2030
    1. Which region has the largest share in the global Endometriosis Treatment market?
    • North America holds the largest share in 2021
    1. Who are the key players in the global Endometriosis Treatment market?
    • Astra Zeneca Plc., Eli Lilly and Company, Astellas Pharma, Bayer AG, Meditrina Pharmaceuticals, Abbvie, PfizerInc, Takeda Pharmaceutica, and Neurocrine Biosciences Inc. are the major companies operating in the global Endometriosis Treatment
    1. Do you offer Post Sale Support?
    • Yes, we offer 16 hours of analyst support to solve the queries
    1. Do you sell particular sections of a report?
    • Yes, we provide regional as well as country-level reports. Other than this we also provide a sectional report. Please get in contact with our sales representatives.

     

     

    Table of Contents

    Table of Contents

    Chapter 1.   Executive Summary

    Chapter 2.   Scope Of Study

                          2.1.   Market Definition

                          2.2.   Scope Of The Study

                                    2.2.1.   Objectives of Report

                                    2.2.2.   Limitations

                          2.3.   Market Structure

    Chapter 3.   Evolve BI Methodology

    Chapter 4.   Market Insights and Trends

                          4.1.   Supply/ Value Chain Analysis

                                    4.1.1.   Raw Application Providers

                                    4.1.2.   Manufacturing Process

                                   4.1.3.   Distributors/Retailers

                                    4.1.4.   End Users

                          4.2.   Porter’s Five Forces Analysis

                                    4.2.1.   Threat Of New Entrants

                                   4.2.2.    Bargaining Power Of Buyers

                                    4.2.3.   Bargaining Power Of Suppliers

                                    4.2.4.   Threat Of Substitutes

                                    4.2.5.   Industry Rivalry

                          4.3.   Impact Of COVID-19 on Endometriosis Treatment

                                    4.3.1.   Impact on Market Size

                                    4.3.2.   End-User Trend, Preferences, and Budget Impact

                                    4.3.3.   Regulatory Framework/Government Policies

                                    4.3.4.   Key Players' Strategy to Tackle Negative Impact

                                    4.3.5.   Opportunity Window

                         4.4.   Technology Overview

                          4.5.   Macro factor

                          4.6.   Micro Factor

                            4.7.   Demand Supply Gap Analysis of Endometriosis Treatment

                            4.8.   Import Analysis of Endometriosis Treatment

                            4.9.   Export Analysis of Endometriosis Treatment

    Chapter 5.   Market Dynamics 

                          5.1.   Introduction

                          5.2.   DROC Analysis

                                    5.2.1.   Drivers

                                    5.2.2.   Restraints

                                    5.2.3.   Opportunities

                                    5.2.4.   Challenges

                          5.3.   Patent Analysis

                          5.4.   Industry Roadmap

                         5.5.   Parent/Peer Market Analysis

    Chapter 6.   Global Endometriosis Treatment, By Drug Type

                          6.1.   Introduction

                          6.2.   Progestin

                          6.3.   Gonadotropins Releasing Hormone Agonists

                          6.4.   Oral Contraceptive Pills

                          6.5.   Non-Steroidal Anti-Inflammatory Drugs

                          6.6     Others

    Chapter 7.   Global Endometriosis Treatment, By Treatment Type

                          7.1.   Introduction

                          7.2.   Hormonal Therapies

                          7.3.   Pain Management

    Chapter 8.   Global Endometriosis Treatment, By Distribution Channel

                          8.1.   Introduction

                          8.2.   Hospital Pharmacies

                          8.3.   E-Pharmacies

                          8.4    Retail Pharmacies

                          8.5    Others

    Chapter 9.   Global Endometriosis Treatment, By Region

                          9.1.   Introduction

                          9.2.   North America

                                    9.2.1.   Introduction

                                    9.2.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                    9.2.3.   Market Size and Forecast, By Country, 2020 - 2028

                                   9.2.4.   Market Size and Forecast, By Product Type, 2020 - 2028

                                    9.2.5.   Market Size and Forecast, By Application, 2020 – 2028

                                    9.2.6.   US

                                                  9.2.6.1.   Introduction

                                                   9.2.6.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                                   9.2.6.3.   Market Size and Forecast, By Product Type, 2020 - 2028

                                                   9.2.6.4.   Market Size and Forecast, By Application, 2020 - 2028

                                    9.2.7.   Canada

                                                   9.2.7.1.   Introduction

                                                   9.2.7.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                                   9.2.7.3.   Market Size and Forecast, By Product Type, 2020 - 2028

                                                  9.2.7.4.   Market Size and Forecast, By Application, 2020 - 2028

                          9.3.   Europe

                                    9.3.1.   Introduction

                                    9.3.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                    9.3.3.   Market Size and Forecast, By Country, 2020 - 2028

                                    9.3.4.   Market Size and Forecast, By Product Type, 2020 - 2028

                                    9.3.5.   Market Size and Forecast, By Application, 2020 – 2028

                                    9.3.6.   Germany

                                                   9.3.6.1.   Introduction

                                                   9.3.6.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                                   9.3.6.3.   Market Size and Forecast, By Product Type, 2020 - 2028

                                                   9.3.6.4.   Market Size and Forecast, By Application, 2020 - 2028

                                    9.3.7.   France

                                                   9.3.7.1.   Introduction

                                                   9.3.7.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                                   9.3.7.3.   Market Size and Forecast, By Product Type, 2020 - 2028

                                                   9.3.7.4.   Market Size and Forecast, By Application, 2020 - 2028

                                    9.3.8.   UK

                                                  9.3.8.1.   Introduction

                                                   9.3.8.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                                   9.3.8.3.   Market Size and Forecast, By Product Type, 2020 - 2028

                                                   9.3.8.4.   Market Size and Forecast, By Application, 2020 - 2028

                                    9.3.9.   Italy

                                                   9.3.9.1.   Introduction

                                                  9.3.9.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                                   9.3.9.3.   Market Size and Forecast, By Product Type, 2020 - 2028

                                                  9.3.9.4.    Market Size and Forecast, By Application, 2020 - 2028

                                    9.3.10.   Rest Of Europe

                                                   9.3.10.1.   Introduction

                                                   9.3.10.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                                   9.3.10.3.   Market Size and Forecast, By Product Type, 2020 - 2028

                                                   9.3.10.4.   Market Size and Forecast, By Application, 2020 - 2028

                          9.4.   Asia-Pacific

                                    9.4.1.   Introduction

                                   9.4.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                    9.4.3.   Market Size and Forecast, By Country, 2020 - 2028

                                    9.4.4.   Market Size and Forecast, By Product Type, 2020 - 2028

                                    9.4.5.   Market Size and Forecast, By Application, 2020 - 2028

                                    9.4.6.   China

                                                   9.4.6.1.   Introduction

                                                  9.4.6.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                                   9.4.6.3.   Market Size and Forecast, By Product Type, 2020 - 2028

                                                   9.4.6.4.   Market Size and Forecast, By Application, 2020 - 2028

                                    9.4.7.   India

                                                   9.4.7.1.   Introduction

                                                   9.4.7.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                                   9.4.7.3.   Market Size and Forecast, By Product Type, 2020 - 2028

                                                   9.4.7.4.   Market Size and Forecast, By Application, 2020 - 2028

                                   9.4.8.   Japan

                                                   9.4.8.1.   Introduction

                                                   9.4.8.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                                  9.4.8.3.   Market Size and Forecast, By Product Type, 2020 - 2028

                                                   9.4.8.4.   Market Size and Forecast, By Application, 2020 - 2028

                                    9.4.9.   South Korea

                                                   9.4.9.1.   Introduction

                                                   9.4.9.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                                   9.4.9.3.   Market Size and Forecast, By Product Type, 2020 - 2028

                                                   9.4.9.4.   Market Size and Forecast, By Application, 2020 - 2028

                                    9.4.10.   Rest Of Asia-Pacific

                                                   9.4.10.1.   Introduction

                                                   9.4.10.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                                  9.4.10.3.   Market Size and Forecast, By Product Type, 2020 - 2028

                                                   9.4.10.4.   Market Size and Forecast, By Application, 2020 - 2028

                          9.5.   Rest Of The World (RoW)

                                    9.5.1.   Introduction

                                    9.5.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                    9.5.3.   Market Size and Forecast, By Product Type, 2020 - 2028

                                   9.5.4.   Market Size and Forecast, By Application, 2020 - 2028

                                    9.5.5.   Market Size and Forecast, By Region, 2020 - 2028

                                    9.5.6.   South America

                                                  9.5.6.1.   Introduction

                                                   9.5.6.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                                   9.5.6.3.   Market Size and Forecast, By Product Type, 2020 - 2028

                                                   9.5.6.4.   Market Size and Forecast, By Application, 2020 - 2028

                                    9.5.7.   Middle East and Africa

                                                   9.5.7.1.   Introduction

                                                   9.5.7.2.   Driving Factors, Opportunity Analyzed, and Key Trends

                                                   9.5.7.3.   Market Size and Forecast, By Product Type, 2020 - 2028

                                                   9.5.7.4.   Market Size and Forecast, By Application, 2020 - 2028

    Chapter 10.    Competitive Landscape

                          10.1.   Introduction

                          10.2.   Vendor Share Analysis, 2020/Key Players Positioning, 2020

    Chapter 11.   Company Profiles

                          11.1.   Astra Zeneca Plc.

                                    11.1.1.   Business Overview

                                    11.1.2.   Financial Analysis

                                    11.1.3.   Product Portfolio

                                    11.1.4.   Recent Development and Strategies Adopted

                                    11.1.5.   SWOT Analysis

                          11.2.  Eli Lilly and Company

                                   11.2.1.   Business Overview

                                    11.2.2.   Financial Analysis

                                    11.2.3.   Product Portfolio

                                    11.2.4.   Recent Development and Strategies Adopted

                                   11.2.5.   SWOT Analysis

                          11.3.   Astellas Pharma

                                    11.3.1.   Business Overview

                                    11.3.2.   Financial Analysis

                                    11.3.3.   Product Portfolio

                                    11.3.4.   Recent Development and Strategies Adopted

                                    11.3.5.   SWOT Analysis

                          11.4.   Bayer AG

                                    11.4.1.   Business Overview

                                   11.4.2.   Financial Analysis

                                    11.4.3.   Product Portfolio

                                    11.4.4.   Recent Development and Strategies Adopted

                                    11.4.5.   SWOT Analysis

                          11.5.   Meditrina Pharmaceuticals

                                    11.5.1.   Business Overview

                                   11.5.2.   Financial Analysis

                                    11.5.3.   Product Portfolio

                                    11.5.4.   Recent Development and Strategies Adopted

                                    11.5.5.   SWOT Analysis

                         11.6.   Abbvie

                                    11.6.1.   Business Overview

                                    11.6.2.   Financial Analysis

                                    11.6.3.   Product Portfolio

                                    11.6.4.   Recent Development and Strategies Adopted

                                    11.6.5.   SWOT Analysis

                          11.7.   Pfizer Inc.

                                   11.7.1.   Business Overview

                                    11.7.2.   Financial Analysis

                                    11.7.3.   Product Portfolio

                                    11.7.4.   Recent Development and Strategies Adopted

                                   11.7.5.   SWOT Analysis

                          11.8.   Takeda Pharmaceutica

                                    11.8.1.   Business Overview

                                    11.8.2.   Financial Analysis

                                    11.8.3.   Product Portfolio

                                    11.8.4.   Recent Development and Strategies Adopted

                                    11.8.5.   SWOT Analysis

                          11.9.   Neurocrine Biosciences Inc.

                                    11.9.1.   Business Overview

                                    11.9.2.   Financial Analysis

                                    11.9.3.   Product Portfolio

                                    11.9.4.   Recent Development and Strategies Adopted

                                    11.9.5.   SWOT Analysis

                  Chapter 12.   Key Takeaways

    Connect to Analyst

    Connect to Analyst













       

       

      Research Methodology

      Research Methodology

      Related products

      Life Science

      COVID-19 Sample Collection Kits Market Analysis and Global Forecast (2021-2028) with COVID Impact Analysis

      $ 3,475.00

      Global COVID-19 Sample Collection Kits Market By Product Type (Swabs, Viral Transport Media, Blood Collection Kits, Other), By Application (Diagnostics, Research, Other), By End-Users (Hospitals & Clinics, Home Test, Others) and By Geography – COVID-19 Impact Analysis, Post COVID Analysis, Opportunities, Trends and Forecast from 2021 to 2028

      Report Code: EB_LS_1095 | Page: 165 | Published Date: April 2021
      Add to cart
      Quick view
      Life Science

      Telemedicine Market Analysis and Global Forecast (2023-2033) with COVID Impact Analysis

      $ 3,475.00
      Telemedicine Market Research Report: By Component (Teleradiology, Telepsychiatry, Telepathology, Teledermatology, Telecardiology, and Other Components), By Component (Software, Hardware, and Services), and By End User (Healthcare Providers, Payers, Healthcare Consumers, and Other End Users), and Region — Forecast till 2033 Report Code: EB_LS_1274 | Page No: 154 | Report Status: Upcoming
      Press Release: https://evolvebi.com/the-telemedicine-market-is-estimated-to-record-a-cagr-of-around-29-2-during-the-forecast-period
      Add to cart
      Quick view
      Life Science

      Allergy Immunotherapy Market Analysis and Global Forecast (2023-2033) with COVID Impact Analysis

      $ 3,475.00
      Allergy Immunotherapy Market Research Report: Information By Treatment Type (Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy (SLIT), By Allergy Type (Allergic rhinitis, Allergic asthma, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and By Region — Forecast till 2033
      Add to cart
      Quick view
      Life Science

      Heart Rate Monitor Market Analysis and Global Forecast (2023-2033) with COVID Impact Analysis

      $ 3,475.00
      Heart Rate Monitor Market Research Report: Information By Product (Wearable and Non-Wearable), By End Users (Hospital and Clinics, Sports Medicine Centers, Professionals, and Individuals), By Indication (Sports and Medical), and By Region — Forecast till 2033
      Add to cart
      Quick view
      Life Science

      Healthcare Analytics Market Analysis and Global Forecast (2023-2033) with COVID Impact Analysis

      $ 3,475.00
      Healthcare Analytics Market Research Report: Information By Type (Descriptive Analysis, Predictive Analysis, Prescriptive Analysis), By Application (Clinical, Financial, Operational, Administrative), By End-Use (Healthcare Payers, Healthcare Providers, Life Science Companies), and By Region — Forecast till 2033
      Add to cart
      Quick view
      Placeholder

      Menstrual Cup market Analysis and Global Forecast (2022-2032) with COVID Impact Analysis

      $ 3,475.00
      Add to cart
      Quick view
      Life Science

      Pharmacogenomics Market Analysis and Global Forecast (2023-2033) with COVID Impact Analysis

      $ 3,475.00
      Pharmacogenomics Market Research Report: Information By Technology (Next Generation Sequencing, Polymerase Chain Reaction, Gel Electrophoresis, Mass Spectrometry, Microarray, Others), By Application (Cardiovascular Disease, Infectious Diseases, Oncology, Neurological Diseases, Psychiatry, Others), By End User (Hospitals And Clinics, Research Institutions, Academic Institutes), and By Region — Forecast till 2033
      Add to cart
      Quick view
      Life Science

      COVID-19 Diagnostics Market Analysis and Global Forecast (2021-2028) with COVID Impact Analysis

      $ 3,475.00

      Global COVID-19 Diagnostics Market By Technology (Molecular, Immunoassay, Others), By Product (PCR Kits, POC Test, Immunoassay Test, Others), By End-User (Hospitals, Diagnostic Labs, Physician's office and urgent care clinics, Others) and By Geography – COVID-19 Impact Analysis, Post COVID Analysis, Opportunities, Trends and Forecast from 2021 to 2028

      Report Code: EB_LS_1101 | Page: 160 | Published Date: April 2021
      Add to cart
      Quick view

      © 2021 Evolve Business Intelligence. All rights reserved. Developed by Nectron


      Privacy Policy | Terms and Conditions | Cancellation and Refund policy

      • Home
      • About Us
      • Services
      • Market Reports
        • Automotive
          • Component
          • Vehicle
          • Chemical Automotive
          • Technology
          • Freight & Logistics
          • Material
          • Technology
          • Transport Mode
          • Utility
          • Vehicle
        • Chemical and Materials
          • Chemical
          • Advanced Materials
          • Coatings and Additives
          • Composites
          • Paints
          • Textile
        • Aerospace & Defense
          • Marine
          • Security
          • Technology
          • Aircraft Components
          • Aircraft Material
        • Construction & Manufacturing
        • Electronics and Semiconductor
          • Display Technology
          • Electronic Component
          • Electronic Devices
          • Semiconductor
          • Communication Equipment
          • Emerging Technologies
          • Security
          • Sensor & Control
          • Technology
        • Energy and Power
        • Life Science
        • Consumer & Goods
          • Baby products and supplies
          • Beauty & Personal Care
          • Consumer
          • Home Products
        • Information and Communication Technology
          • Emerging Technologies
          • Entertainment Technologies
          • Security
          • Communication
          • Data Center
          • Data Center and Networking
          • Software and Services
          • Technology
      • Competitive Intelligence (CI)
        • Automotive (CI)
        • Chemical and Materials (CI)
        • Construction & Manufacturing (CI)
        • Energy and Power (CI)
        • Electronics and Semiconductor (CI)
        • Healthcare (CI)
        • Information and Communication Technology ICT (CI)
      • Become a reseller
      • Contact Us
      We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies.
      More info Accept
      I allow the Site owner to contact me via email/phone to discuss this enquiry. (If you want to know more about the way this site handles the data, then please go through our privacy policy).
      Brought to you by WisdmLabs: WordPress Development Experts

      Sending...